The quest for optimal and reliable guidelines based on robust evidence for the treatment of cholangiocarcinoma

Hepatobiliary Surg Nutr. 2021 Dec;10(6):913-915. doi: 10.21037/hbsn-21-117.

Daniel Azoulay¹, David Bomze², Tomer Meirson^{3

4}

¹ Centre Hépato-Biliaire, Assistance Publique-Hôpitaux de Paris, Hôpital Universitaire Paul Brousse, Institut National de la Santé et de la Recherche Médicale (INSERM) Unité 935, and Université Paris-Saclay, Villejuif, France.
² Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
³ Ella Lemelbaum Institute for Immuno-oncology, Sheba Medical Center, Ramat-Gan, Israel.
⁴ The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

No abstract available

Publication types